Sat.Apr 06, 2024

article thumbnail

STAT+: Positive trial results set up obesity drug Wegovy for use against heart failure

STAT

ATLANTA — Novo Nordisk’s Wegovy improved symptoms and physical function in patients who had obesity, diabetes, and a common type of heart failure, boosting Novo’s attempt to get the popular drug approved for yet another usage beyond weight loss. The study, being presented here on Saturday at the American College of Cardiology conference and published in the New England Journal of Medicine , reports results from the second large trial Novo has conducted on Wegovy in heart fai

Diabetes 338
article thumbnail

Bayer signs marketing and distribution agreement with Dr Reddy’s for second brand of Vericiguat in India

Express Pharma

Under this new partnership, Dr Reddy’s will market the drug under a second brand name Gantra in India, expanding the reach of vericiguat to meet the needs of patients with Chronic Heart Failure with reduced ejection fraction (less than 45 per cent) Dr Reddy’s Laboratories and Bayer announced that both companies have entered into a partnership to market and distribute a second brand of Vericiguat in India.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: STAT readers on biotech and national security, liquid-only diets before colonoscopy, and the value of weight loss drugs

STAT

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “For national security, the U.S.

198
198
article thumbnail

Effective Customer Communication | Case Study

PharmaState Academy

CASE STUDY Effective Customer Communication - Launching a New Drug in Rural India Table of Contents Case Study Introduction: As the leader of the marketing team at ABCG Pharmaceuticals, you oversee the launch of a groundbreaking new drug designed to address a prevalent health issue in rural India. Effective communication with healthcare providers and patients in remote areas is essential to ensure the successful adoption and utilization of the new medication.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Low-Dose Naltrexone (LDN) | A Promising Treatment For Rheumatoid Arthritis

Welltopia Pharmacy

Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by inflammation, pain, and joint destruction, significantly impacting patients’ quality of

article thumbnail

New patent expiration for Galderma Labs drug ORACEA

Drug Patent Watch

Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers.

52

More Trending

article thumbnail

Which pharmaceutical drugs have the most drug patents in Russian Federation?

Drug Patent Watch

This chart shows the drugs with the most patents in Russian Federation.

95
article thumbnail

Challenges and Opportunities for Pharmacists in Clinical Research

Pharmacy Times

Although the number of clinical trials has quadrupled, the number of FDA approvals remains stable over a 10-year period, highlighting workforce challenges in clinical research.

20